Allink Biotherapeutics

Allink Biotherapeutics is a biotechnology company focused on the research and development of innovative drugs. Based on its self-developed bispecific antibody and ADC technology platforms, the company has established a series of innovative product pipelines with first-in-class (FIC) and best-in-class (BIC) potential. Allink Biotherapeutics is committed to developing breakthrough therapies in the fields of oncology and immune diseases, bringing innovative treatment solutions to patients worldwide.